The University of Michigan Medical School has announced it will no longer take money from drug and device companies to pay for continuing medical education courses. Dean James Woolliscroft, MD, commented in the New York Times that leading faculty members “wanted education to be free from bias, to be based on the best evidence and a balanced view of the topic under discussion.”
As mentioned by The Ticker blog, other medical schools have opted in recent years to restrict industry support for continuing medical education. Stanford is one such place: As of 2008, the medical school no longer accepts company support for specific CME programs. And earlier this year, it announced a new educational model that will involve industry but "be guided by the needs of physician/learners, rather than by commercial interests."